Difference between revisions of "Part:BBa K4800015"

Line 24: Line 24:
 
         <strong>Figure 1 Colony PCR results of strain containing pTrc99a-GabT</strong>
 
         <strong>Figure 1 Colony PCR results of strain containing pTrc99a-GabT</strong>
 
     </div>
 
     </div>
     <p>
+
     <p><br>
         Plasmid pTrc99a-GabT were transferred into strain <i>E. coli</i> BL21 to determine its express. The cells were inoculated and cultured in the LB medium at 37℃. 0.5 mM of IPTG was added into the culture to induce protein expression when cells grew into an OD600 of 0.6-0.8. After overnight induction and cultivation, the cells were harvested  and resuspended in 50 mM Tris-HCl buffer (pH 8.0). The suspended cells were then lysed by ultrasonication to release the intracellular proteins. SDS-PAGE results confirmed that the molecular weight of GabT protein was correct, which was consistent with the expected molecular weight of 43.0 kDa (Figure 2).
+
         Plasmid pTrc99a-GabT were transferred into strain <i>E. coli</i> BL21 to determine its express. The cells were inoculated and cultured in the LB medium at 37℃. 0.05 mM of IPTG was added into the culture to induce protein expression when cells grew into an OD<sub>600</sub> of 0.6-0.8. After overnight induction and cultivation, the cells were harvested  and resuspended in 50 mM Tris-HCl buffer (pH 8.0). The suspended cells were then lysed by ultrasonication to release the intracellular proteins. SDS-PAGE results confirmed that the molecular weight of GabT protein was correct, which was consistent with the expected molecular weight of 43.0 kDa (Figure 2).
 
     </p>
 
     </p>
 
     <div align="center">
 
     <div align="center">
Line 44: Line 44:
 
         <strong>Figure 3 Determining the activity of GabT by a cascade reaction</strong>
 
         <strong>Figure 3 Determining the activity of GabT by a cascade reaction</strong>
 
     </div>
 
     </div>
     <p>
+
     <p><br>
         Next, we test the activity GabT for the 1,5-PDO production when it was co-expressed with carboxylate reductase MmCAR and aldehyde reductase of Yahk by a whole cell process. We used 5-AVA as the starting substrate for whole-cell catalysis. As shown in Figure 4, the production of 1,5-PDO by a cascade reaction containing GabT was successfully detected, indicating that GabT could be employed as a component in the synthetic 1,5-PDO pathway for its production.
+
         Next, we test the activity GabT for the 1,5-pentanediol (1,5-PDO) production when it was co-expressed with carboxylate reductase MmCAR and aldehyde reductase of Yahk by a whole cell process. We used 5-AVA as the starting substrate for whole-cell catalysis. As shown in Figure 4, the production of 1,5-PDO by a cascade reaction containing GabT was successfully detected, indicating that GabT could be employed as a component in the synthetic 1,5-PDO pathway for its production.
 
     </p>
 
     </p>
 
     <div align="center">
 
     <div align="center">
Line 53: Line 53:
 
         <strong>Figure 4 The activity GabT for the 1,5-PDO production in a whole-cell process</strong>
 
         <strong>Figure 4 The activity GabT for the 1,5-PDO production in a whole-cell process</strong>
 
     </div>
 
     </div>
     <p>
+
     <p><br>
 
         After obtaining the results of whole-cell catalysis, we chose to use GabT as the transaminase to construct 1,5-PDO fermentation strains for further verification. Two plasmids including pTrc99a-davB-davA-GabT (<a href='https://parts.igem.org/Part:BBa_K4800054'>BBa_K4800054</a>) and pACYCDuet-sfp-MmCAR-YahK (<a href='https://parts.igem.org/Part:BBa_K4800053'>BBa_K4800053</a>) were constructed and transformed into <i>E. coli</i> NT1003 strain to obtain the engineered strain of <i>E. coli</i> NT1003-P1. After the fermentation of 72 h, the fermentation broth contained 2.82 mM (0.293 g/L) of 1,5-PDO (Figure 5).
 
         After obtaining the results of whole-cell catalysis, we chose to use GabT as the transaminase to construct 1,5-PDO fermentation strains for further verification. Two plasmids including pTrc99a-davB-davA-GabT (<a href='https://parts.igem.org/Part:BBa_K4800054'>BBa_K4800054</a>) and pACYCDuet-sfp-MmCAR-YahK (<a href='https://parts.igem.org/Part:BBa_K4800053'>BBa_K4800053</a>) were constructed and transformed into <i>E. coli</i> NT1003 strain to obtain the engineered strain of <i>E. coli</i> NT1003-P1. After the fermentation of 72 h, the fermentation broth contained 2.82 mM (0.293 g/L) of 1,5-PDO (Figure 5).
 
     </p>
 
     </p>
Line 64: Line 64:
 
         </strong>
 
         </strong>
 
     </div>
 
     </div>
     <p>
+
     <p><br>
 
         We further expressed the plasmid pTrc99a-davB-davA-GabT containing GabT together with the plasmid of pRSFDuet-sfp-MmCAR-YahK (<a href='https://parts.igem.org/Part:BBa_K4800055'>BBa_K4800055</a>) to obtain the engineered strain <i>E. coli</i> NT1003-P2. Similarly, 8.09 mM (0.843 g/L) 1,5-PDO could be successfully produced by the engineered strain <i>E. coli</i> NT1003-P2 (Figure 6).
 
         We further expressed the plasmid pTrc99a-davB-davA-GabT containing GabT together with the plasmid of pRSFDuet-sfp-MmCAR-YahK (<a href='https://parts.igem.org/Part:BBa_K4800055'>BBa_K4800055</a>) to obtain the engineered strain <i>E. coli</i> NT1003-P2. Similarly, 8.09 mM (0.843 g/L) 1,5-PDO could be successfully produced by the engineered strain <i>E. coli</i> NT1003-P2 (Figure 6).
 
     </p>
 
     </p>
Line 75: Line 75:
 
         </strong>
 
         </strong>
 
     </div>
 
     </div>
     <p>
+
     <p><br>
 
         These results confirmed that GabT enabled the synthesis of 1,5-PDO in <i>E. coli</i> through an artificial synthetic pathway, which support us to do the following strain optimization design and provided a good basis for the subsequent construction of 1,5-PDO producing strains.
 
         These results confirmed that GabT enabled the synthesis of 1,5-PDO in <i>E. coli</i> through an artificial synthetic pathway, which support us to do the following strain optimization design and provided a good basis for the subsequent construction of 1,5-PDO producing strains.
 
     </p>
 
     </p>

Revision as of 09:25, 12 October 2023


GabT

GabT, 4-aminobutyrate-2-oxoglutarate transaminase from Escherichia coli K-12 is the initial enzyme of one of two 4-aminobutyrate (GABA) degradation pathways. It belongs to the aminotransferase subgroup II of pyridoxal 5'-phosphate (PLP)-dependent enzymes, which requires pyridoxal phosphate to function. GabT also functions as a 5-aminovalerate aminotransferase during degradation of L-lysine.


Characterization

The gene of GabT was amplified from the genome of E. coli MG1655, and integrated into pTrc99a vector to obtain the plasmid pTrc99a-GabT (BBa_K4800046). We performed colony PCR on bacteria containing the existing pTrc99a-GabT plasmid. Based on the results of colony PCR, the gene fragment of GabT was between 1000 and 2000 bp (Figure 1), which was consistent with our expectation of the fragment size of GabT.

Figure 1 Colony PCR results of strain containing pTrc99a-GabT


Plasmid pTrc99a-GabT were transferred into strain E. coli BL21 to determine its express. The cells were inoculated and cultured in the LB medium at 37℃. 0.05 mM of IPTG was added into the culture to induce protein expression when cells grew into an OD600 of 0.6-0.8. After overnight induction and cultivation, the cells were harvested and resuspended in 50 mM Tris-HCl buffer (pH 8.0). The suspended cells were then lysed by ultrasonication to release the intracellular proteins. SDS-PAGE results confirmed that the molecular weight of GabT protein was correct, which was consistent with the expected molecular weight of 43.0 kDa (Figure 2).

Figure 2 SDS-PAGE analysis of GabT expression in E. coli BL21

Determining the activity and usage for 1, 5-pentanediol production

GabT catalyzes 5-aminovalerate to glutarate semialdehyde. As the instability and detection difficulty of glutarate semialdehyde, we determined the activity of GabT in a cascade reaction with aldehyde reductase of Yahk by detecting the 5-hydroxyvalerate production. The cell that contained empty plasmid was used as the control. As the results shown in Figure 3, GabT from E. coli exhibited the ammonia transfer activity towards 5-aminovalerate, and the product of 5-hydroxyvalerate was successfully detected.

Figure 3 Determining the activity of GabT by a cascade reaction


Next, we test the activity GabT for the 1,5-pentanediol (1,5-PDO) production when it was co-expressed with carboxylate reductase MmCAR and aldehyde reductase of Yahk by a whole cell process. We used 5-AVA as the starting substrate for whole-cell catalysis. As shown in Figure 4, the production of 1,5-PDO by a cascade reaction containing GabT was successfully detected, indicating that GabT could be employed as a component in the synthetic 1,5-PDO pathway for its production.

Figure 4 The activity GabT for the 1,5-PDO production in a whole-cell process


After obtaining the results of whole-cell catalysis, we chose to use GabT as the transaminase to construct 1,5-PDO fermentation strains for further verification. Two plasmids including pTrc99a-davB-davA-GabT (BBa_K4800054) and pACYCDuet-sfp-MmCAR-YahK (BBa_K4800053) were constructed and transformed into E. coli NT1003 strain to obtain the engineered strain of E. coli NT1003-P1. After the fermentation of 72 h, the fermentation broth contained 2.82 mM (0.293 g/L) of 1,5-PDO (Figure 5).

Figure 5 The usage of GabT to construct an engineered strain of E. coli NT1003-P1 to produce 1,5-pentanediol from glucose via a fermentation


We further expressed the plasmid pTrc99a-davB-davA-GabT containing GabT together with the plasmid of pRSFDuet-sfp-MmCAR-YahK (BBa_K4800055) to obtain the engineered strain E. coli NT1003-P2. Similarly, 8.09 mM (0.843 g/L) 1,5-PDO could be successfully produced by the engineered strain E. coli NT1003-P2 (Figure 6).

Figure 6 The usage of GabT to construct an engineered strain of E. coli NT1003-P2 to produce 1,5-pentanediol from glucose via a fermentation


These results confirmed that GabT enabled the synthesis of 1,5-PDO in E. coli through an artificial synthetic pathway, which support us to do the following strain optimization design and provided a good basis for the subsequent construction of 1,5-PDO producing strains.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 328
  • 1000
    COMPATIBLE WITH RFC[1000]